G1 THERAPEUTICS

g1-therapeutics-logo

G1 Therapeutics is a clinical-stage company developing novel cancer therapies. It is also advancing rintodestrant, a potential oral selective estrogen receptor degrader, or serd, for the treatment of er+ breast cancer. It is committed to improving the lives of those impacted by cancer. It is also executing a tumor-agnostic development program, with late-stage clinical trials ongoing in multiple tumor types.

#SimilarOrganizations #People #Financial #Event #Website #More

G1 THERAPEUTICS

Social Links:

Industry:
Biotechnology Developer Platform Medical Therapeutics

Founded:
2008-01-01

Address:
Durham, North Carolina, United States

Country:
United States

Website Url:
http://www.g1therapeutics.com

Total Employee:
101+

Status:
Active

Contact:
+1 919 213 9835

Email Addresses:
[email protected]

Total Funding:
497.32 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Universal Analytics Apache Microsoft Exchange Online Amazon


Similar Organizations

enliven-therapeutics-logo

Enliven Therapeutics

Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.

hookipa-pharma-logo

Hookipa Pharma

Hookipa is a clinical stage biotech company developing best-in-class active immunization therapies for infectious diseases and oncology.

proteostasis-therapeutics-logo

Proteostasis Therapeutics

Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.

scholar-rock-logo

Scholar Rock

Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.


Current Advisors List

seth-rudnick_image

Seth Rudnick Chairman @ G1 Therapeutics
Board_member
2014-01-07

christy-l-shaffer_image

Christy L. Shaffer Executive Chair, Board @ G1 Therapeutics
Board_member

jack-bailey_image

Jack Bailey Board Member @ G1 Therapeutics
Board_member
2020-03-01

Current Employees Featured

rajesh-malik_image

Rajesh Malik
Rajesh Malik Chief Medical Officer @ G1 Therapeutics
Chief Medical Officer
2014-01-01

not_available_image

Jay Strum
Jay Strum Chief Scientific Officer @ G1 Therapeutics
Chief Scientific Officer

terry-murdock_image

Terry Murdock
Terry Murdock Chief Operating Officer @ G1 Therapeutics
Chief Operating Officer
2017-08-01

greg-mossinghoff_image

Greg Mossinghoff
Greg Mossinghoff Chief Business Officer @ G1 Therapeutics
Chief Business Officer

jennifer-moses_image

Jennifer Moses
Jennifer Moses Chief Financial Officer & VP of Finance @ G1 Therapeutics
Chief Financial Officer & VP of Finance
2019-05-01

ostra-jewell_image

Ostra Jewell
Ostra Jewell Vice President Human Resources @ G1 Therapeutics
Vice President Human Resources
2019-08-01

mark-avagliano_image

Mark Avagliano
Mark Avagliano Chief Business Officer @ G1 Therapeutics
Chief Business Officer
2019-01-01

andrew-perry_image

Andrew Perry
Andrew Perry Chief Commercial Officer @ G1 Therapeutics
Chief Commercial Officer
2021-08-01

greg-maxfield_image

Greg Maxfield
Greg Maxfield VP & Market Access @ G1 Therapeutics
VP & Market Access
2020-06-01

jack-bailey_image

Jack Bailey
Jack Bailey CEO @ G1 Therapeutics
CEO
2021-01-01

Founder


kwok-kin-wong_image

Kwok-Kin Wong

norman-sharpless_image

Norman Sharpless

Stock Details


Company's stock symbol is NASDAQ:GTHX

Investors List

herculescapital_image

Hercules Capital

Hercules Capital investment in Post-IPO Debt - G1 Therapeutics

tavistock-life-sciences_image

Tavistock Life Sciences

Tavistock Life Sciences investment in Series C - G1 Therapeutics

franklin-templeton-investments_image

Franklin Templeton Investments

Franklin Templeton Investments investment in Series C - G1 Therapeutics

cowen-group_image

Cowen Group

Cowen Group investment in Series C - G1 Therapeutics

cormorant-asset-management_image

Cormorant Asset Management

Cormorant Asset Management investment in Series C - G1 Therapeutics

eshelman-ventures_image

Eshelman Ventures

Eshelman Ventures investment in Series C - G1 Therapeutics

aju-ib-investment_image

Aju IB Investment

Aju IB Investment investment in Series C - G1 Therapeutics

hatteras-venture-partners_image

Hatteras Venture Partners

Hatteras Venture Partners investment in Series C - G1 Therapeutics

mountain-group-capital_image

Mountain Group Capital

Mountain Group Capital investment in Series C - G1 Therapeutics

lumira-ventures_image

Lumira Ventures

Lumira Ventures investment in Series C - G1 Therapeutics

Official Site Inspections

http://www.g1therapeutics.com Semrush global rank: 3.87 M Semrush visits lastest month: 3.34 K

  • Host name: ec2-34-192-255-123.compute-1.amazonaws.com
  • IP address: 34.192.255.123
  • Location: Ashburn United States
  • Latitude: 39.0481
  • Longitude: -77.4728
  • Metro Code: 511
  • Timezone: America/New_York
  • Postal: 20149

Loading ...

More informations about "G1 Therapeutics" on Search Engine